Mylan N.V.and Pfizer announced the appointment of Sanjeev Narula as CFO of Viatris. He is currently working as Chief Financial Officer of Upjohn, a division of Pfizer. Viatris is the new company that will result from the planned combination of Mylan and Upjohn.
Narula has been working with Pfizer for over 16 years. At Upjohn, he has worked closely with incoming Viatris CEO Michael Goettler. Narula has broad knowledge of the generic and branded pharmaceutical business, having previously served as Vice President, Finance, for Pfizer’s Essential Health Business. Narula has also served as the Finance lead for the Primary Care Business Unit, the largest commercial division at the time. Prior to joining Pfizer, Narula had financial and operational leadership roles at American Express and Xerox.
Pfizer Chairman and CEO Albert Bourla said: “Sanjeev’s global experience, proven leadership, and deep industry knowledge will serve Viatris employees, customers and shareholders well. I am very confident that his commitment to excellence will be instrumental as the new company charts its path as a champion for global health.”
Group President, Upjohn, and incoming Viatris CEO Michael Goettler said, “I’ve had the privilege of working closely with Sanjeev to establish the Upjohn business and now prepare for the launch of Viatris. His dedication, extensive knowledge of the pharmaceutical industry and deep financial and operational expertise will be essential to the Viatris leadership team as we work to ensure that the new company is set up for success.”
Narula said: “I look forward to partnering closely with the Viatris leadership team and Board of Directors, as well as with the investment community, to help ensure the strength of Viatris’ financial performance through consistent earnings and cash flow growth, an attractive dividend and shareholder-focused capital policies.”
As the Viatris CFO, Narula will report to Michael Goettler, who was previously announced as incoming CEO of Viatris. The Mylan and Upjohn teams will continue to work together over the coming months to fill additional leadership positions and further its comprehensive integration planning efforts. The transaction remains on track to close in mid-2020, subject to receipt of regulatory approvals, Mylan shareholder approval, and the satisfaction of other customary closing conditions. Mylan and Upjohn will continue to operate as independent organizations under their existing organization structures until the transaction closes.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.